Form 4: Accolade Inc. Executive Cavanaugh Reports Stock Transactions

Robert N. Cavanaugh, President of Accolade, Inc., reports the conversion of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• On February 10, 2025, Robert N. Cavanaugh, President of Accolade, Inc., converted 711 Restricted Stock Units (RSUs) into common stock.
• Following the conversion, Mr. Cavanaugh sold 252 shares of common stock on February 11, 2025, at a price of $6.885 per share.
• The sale was to cover tax withholding obligations related to the vesting and settlement of the RSUs and was not a discretionary transaction.
• After these transactions, Mr. Cavanaugh directly owns 216,559 shares of Accolade, Inc. common stock and 2,843 Restricted Stock Units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings to understand management's perspective on the company's stock and financial health.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The transactions reported are typical for executives receiving stock-based compensation.
• Similar filings are made by executives at companies like Teladoc Health and Livongo, which operate in related healthcare technology sectors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares sold.
• The sale to cover tax obligations ensures compliance with tax regulations.

Key Dates

Keywords

Accolade Inc., Robert N. Cavanaugh, ACCD, Form 4, Stock Sale, RSU, Restricted Stock Units, Beneficial Ownership, Insider Trading